| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |